详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes (vol 13, 836958, 2022)

120| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thyroid & Breast Surg, Wuhan, Peoples R China [2]Harbin Med Univ, Harbin Med Univ Canc Hosp, Dept Gastrointestinal Surg, Harbin, Peoples R China

出处：

DOI：

ISSN：

关键词： gastric cancer controlling nutritional status immune checkpoint inhibitors PD-1 PD-L1

语种：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 2 区

医学

小类 | 2 区药学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区药学

JCR分区：

出版当年[2020]版：

Q1 PHARMACOLOGY & PHARMACY

最新[2023]版：

Q1 PHARMACOLOGY & PHARMACY

影响因子： 4.4 最新[2023版] 5 最新五年平均 5.811 出版当年[2020版] 6.006 出版当年五年平均 4.225 出版前一年[2019版] 5.988 出版后一年[2021版]

第一作者：

第一作者单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thyroid & Breast Surg, Wuhan, Peoples R China [2]Harbin Med Univ, Harbin Med Univ Canc Hosp, Dept Gastrointestinal Surg, Harbin, Peoples R China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes. [2]The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors [3]Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors [4]Gut microbiome modulates efficacy of immune checkpoint inhibitors [5]PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities [6]HCC treated with immune checkpoint inhibitors: a hyper-enhanced rim on Sonazoid-CEUS Kupffer phase images is a predictor of tumor response [7]Research progress of PD-1/PD-L1 immunotherapy in gastrointestinal tumors [8]PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance [9]Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors [10]Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer